彭

彭奕冰 (Yibing Peng)

shanghai jiao tong university

H指数:21

被引数:1,202

个人简介

"学科代码：100208 性别：女学科名称：临床检验诊断学培养单位：附属瑞金医院三级学科专业领域名称：临床检验诊断学专业学位联系方式：上海市黄浦区瑞金二路197号瑞金医院门诊大楼6楼检验科邮编：200025"

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Meropenem Stress Drives Lipid Remodeling and Resistance Gene Dissemination via Outer Membrane Vesicles in Carbapenem-Resistant Klebsiella pneumoniae

美罗培南胁迫通过外膜囊泡驱动脂质重塑和耐药基因在碳青霉烯耐药肺炎克雷伯菌中的传播

Current Research in Microbial Sciences

IF5.8

2026-05-270

OAAI

The prevalence and molecular epidemiology of Clostridioides difficile in hospital-based pediatric populations in China

Emerging Microbes and Infections

IF7.5

2026-01-220

PRE

Madecassoside alleviates Clostridioides difficile infection by targeting ASC to inhibit inflammasome activation

马德卡索苷通过靶向ASC来抑制NLRP3炎性体激活，从而缓解艰难梭菌感染。

International Immunopharmacology

IF4.7

2025-08-290

PRE

Metabolic shifts in tryptophan pathways during acute pancreatitis infections

急性胰腺炎感染期间色氨酸通路中的代谢转变

JCI INSIGHT

IF6.1

2025-03-100

Risk factors for bloodstream infection among patients admitted to an intensive care unit of a tertiary hospital of Shanghai, China

SCIENTIFIC REPORTS

IF3.9

2024-06-043

OAAI

Bile acid profiling as an effective biomarker for staging in pediatric inflammatory bowel disease

GUT MICROBES

IF11

2024-03-043

OAAI

Systematic identification and characterization of five transcription factors mediating the oxidative stress response in Candida albicans

MICROBIAL PATHOGENESIS

IF3.5

2024-02-013

OAAI

The regulatory subunits of CK2 complex mediate DNA damage response and virulence in Candida Glabrata

CK2复合物的调节亚基介导光滑念珠菌的DNA损伤反应和毒力

BMC MICROBIOLOGY

IF4.2

2023-10-281

OAAI

Altered intestinal microbiome and metabolome correspond to the clinical outcome of sepsis

CRITICAL CARE

IF9.3

2023-03-2828

OAAI

Clostridioides difficile aggravates dextran sulfate solution (DSS)-induced colitis by shaping the gut microbiota and promoting neutrophil recruitment

GUT MICROBES

IF11

2023-03-2315

OAAI

A dual action small molecule enhances azoles and overcomes resistance through co-targeting Pdr5 and Vma1

TRANSLATIONAL RESEARCH

IF5.9

2022-09-012

PRE

Complete Genome Sequencing and Comparative Phenotypic Analysis Reveal the Discrepancy Between Clostridioides difficile ST81 and ST37 Isolates

FRONTIERS IN MICROBIOLOGY

IF4.5

2021-12-215

OAAI

Repurposing the FDA-approved anticancer agent ponatinib as a fluconazole potentiator by suppression of multidrug efflux and Pma1 expression in a broad spectrum of yeast species

MICROBIAL BIOTECHNOLOGY

IF5.2

2021-05-069

OAAI

Risk factors and intestinal microbiota: Clostridioides difficile infection in patients receiving enteral nutrition at Intensive Care Units

CRITICAL CARE

IF9.3

2020-07-1313

OAAI

FDA Approved Drug Library Screening Identifies Robenidine as a Repositionable Antifungal

FRONTIERS IN MICROBIOLOGY

IF4.5

2020-06-0319

OAAI

Risk factors for Clostridioides difficile infection and colonization among patients admitted to an intensive care unit in Shanghai, China

BMC INFECTIOUS DISEASES

IF3

2019-11-1120

OAAI

Effects of intestinal colonization by Clostridium difficile and Staphylococcus aureus on microbiota diversity in healthy individuals in China

BMC INFECTIOUS DISEASES

IF3

2018-05-0323

OAAI

Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome

CLINICAL CHEMISTRY AND LABORATORY MEDICINE

IF3.7

2017-11-2286

OAAI

Performance of ROMA based on Architect CA 125 II and HE4 values in Chinese women presenting with a pelvic mass: A multicenter prospective study

CLINICA CHIMICA ACTA

IF2.9

2017-08-0116

PREAI

Significance of hyphae formation in virulence of Candida tropicalis and transcriptomic analysis of hyphal cells

MICROBIOLOGICAL RESEARCH

IF6.9

2016-11-0129

OAAI

彭奕冰 (Yibing Peng)

个人简介

教育背景

工作经历

荣誉奖项

研究方向